Direct inhibition of G1 cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation

EMBO Journal

Volumn 18, Issue 24, 1999, Pages 6983-6993

  Zhang, Jian Min ^a   Zhao, Xiaohang ^a   Wei, Qin ^a   Paterson, Bruce M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cell cycle; G1 cdks; MyoD; Myogenesis

Indexed keywords

CYCLIN D; CYCLIN D1; CYCLIN DEPENDENT KINASE; HELIX LOOP HELIX PROTEIN; HYBRID PROTEIN; MYOGENIC FACTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; ENZYME INHIBITION; MOUSE; MYOBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

ANIMALIA;

EID: 0033572867     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.24.6983     Document Type: Article

References (64)

1. Brennan, T.J., Edmondson, D.G. and Olson, E.N. (1990) Aberrant regulation of MyoD1 contributes to the partially defective myogenic phenotype of BC3H1 cells (published erratum appears in J. Cell Biol., 1990, 110, 2231). J. Cell Biol, 110, 929-937.
2. Buckingham, M. (1992) Making muscle in mammals. Trends Genet., 8, 144-148.
3. Chen, L., Krause, M., Sepanski, M. and Fire, A. (1994) The Caenorhabditis elegans MYOD homologue HLH-1 is essential for proper muscle function and complete morphogenesis. Development, 120, 1631-1641.
4. Chen, P.L., Scully, P., Shew, J.Y., Wang, J.Y. and Lee, W.H. (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell, 58, 1193-1198.
5. Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J., 18, 1571-1583.
6. Coleman, K.G., Wautlet, B.S., Morrissey, D., Mulheron, J., Sedman, S.A., Brinkley, P., Price, S. and Webster, K.R. (1997) Identification of CDK4 sequences involved in cyclin D1 and p16 binding. J. Biol. Chem., 272, 18869-18874.
7. Crescenzi, M., Fleming, T.P., Lassar, A.B., Weintraub, H. and Aaronson, S.A. (1990) MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc. Natl Acad. Sci. USA, 87, 8442-8446.
8. 1 checkpoint control. Cell, 82, 675-684.
9. Diehl, J.A. and Sherr, C.J. (1997) A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol. Cell. Biol., 17, 7362-7374.
10. Dyson, N. (1998) The regulation of E2F by pRB-family proteins. Genes Dev., 12, 2245-2262.
11. Emerson, C.P.,Jr (1993) Skeletal myogenesis: genetics and embryology to the fore. Curr. Opin. Genet. Dev., 3, 265-274.
12. Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kato, J. and Livingston, D.M. (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73, 487-497.
13. Fields, S. and Sternglanz, R. (1994) The two-hybrid system: an assay for protein-protein interactions. Trends Genet., 10, 286-292.
14. Furukawa, Y., DeCaprio, J.A., Freedman, A., Kanakura, Y., Nakamura, M., Ernst, T.J., Livingston, D.M. and Griffin, J.D. (1990) Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc. Natl Acad. Sci. USA, 87, 2770-2774.
15. Gorman, C.M., Merlino, G.T., Willingham, M.C., Pastan, I. and Howard, B.H. (1982) The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc. Natl Acad. Sci. USA, 79, 6777-6781.
16. Gu, W., Schneider, J.W., Condorelli, G., Kaushal, S., Mahdavi, V. and Nadal-Ginard, B. (1993) Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell, 72, 309-324.
17. Halevy, O., Novitch, B.G., Spicer, D.B., Skapek, S.X., Rhee, J., Hannon, G.J., Beach, D. and Lassar, A.B. (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science, 267, 1018-1021.
18. Helin, K., Harlow, E. and Fattaey, A. (1993) Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol., 13, 6501-6508.
19. Jeffrey, P.D., Russo, A.A., Polyak, K., Gibbs, E., Hurwitz, J., Massague, J. and Pavletich, N.P. (1995) Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature, 376, 313-320.
20. Kaelin, W.G.Jr, Pallas, D.C., DeCaprio, J.A., Kaye, F.J. and Livingston, D.M. (1991) Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell, 64, 521-532.
21. Kato, J., Matsushime, H., Hiebert, S.W., Ewen, M.E. and Sherr, C.J. (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev., 7, 331-342.
22. Kato, J.Y., Matsuoka, M., Strom, D.K. and Sherr, C.J. (1994) Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol., 14, 2713-2721.
23. Kaye, F.J., Kratzke, R.A., Gerster, J.L. and Horowitz, J.M. (1990) A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc. Natl Acad. Sci. USA, 87, 6922-6926.
24. Kitagawa, M. et al. (1996) The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J., 15, 7060-7069.
25. Knudsen, E.S. and Wang, J.Y. (1997) Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol. Cell. Biol., 17, 5771-5783.
26. LaBaer, J., Garrett, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A. and Harlow, E. (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11, 847-862.
27. Lassar, A. and Munsterberg, A. (1994) Wiring diagrams: regulatory circuits and the control of skeletal myogenesis. Curr. Opin. Cell Biol., 6, 432-442.
28. Lassar, A.B., Davis, R.L., Wright, W.E., Kadesch, T, Murre, C., Voronova, A., Baltimore, D. and Weintraub, H. (1991) Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell, 66, 305-315.
29. Lassar, A.B., Skapek, S.X. and Novitch, B. (1994) Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol., 6, 788-794.
30. K1P2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev., 9, 639-649.
31. Lin, Z.Y., Dechesne, C.A., Eldridge, J. and Paterson, B.M. (1989) An avian muscle factor related to MyoD1 activates muscle-specific promoters in nonmuscle cells of different germ-layer origin and in BrdU-treated myoblasts. Genes Dev., 3, 986-996.
32. Lindon, C., Montarras, D. and Pinset, C. (1998) Cell cycle-regulated expression of the muscle determination factor Myf5 in proliferating myoblasts. J. Cell Biol., 140, 111-118.
33. Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J. and Kato, J.Y. (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14, 2066-2076.
34. Megeney, L.A., Kablar, B., Garrett, K., Anderson, J.E. and Rudnicki, M.A. (1996) MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev., 10, 1173-1183.
35. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol., 14, 2077-2086.
36. Meyerson, M., Enders, G.H., Wu, C.L., Su, L.K., Gorka, C., Nelson, C., Harlow, E. and Tsai, L.H. (1992) A family of human cdc2-related protein kinases. EMBO J., 11, 2909-2917.
37. Miller, J.B. (1990) Myogenic programs of mouse muscle cell lines: expression of myosin heavy chain isoforms, MyoD1 and myogenin. J. Cell Biol., 111, 1149-1159.
38. Mueller, P.R. and Wold, B. (1989) In vivo footprinting of a muscle specific enhancer by ligation mediated PCR (published erratum appears in Science, 1990, 248, 802). Science, 246, 780-786.
39. 2 phases of the cell cycle. J. Cell Biol., 135, 441-456.
40. Okamoto, A. et al (1994) Mutations and altered expression of p16INK4 in human cancer. Proc. Natl Acad. Sci. USA, 91, 11045-11049.
41. Olson, E.N. (1992) Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol., 154, 261-272.
42. Cip1 in muscle and other terminally differentiating cells. Science, 267, 1024-1027.
43. Paterson, B.M., Walldorf, U., Eldridge, J., Dubendorfer, A., Frasch, M. and Gehring, W.J. (1991) The Drosophila homologue of vertebrate myogenic-determination genes encodes a transiently expressed nuclear protein marking primary myogenic cells. Proc. Natl Acad. Sci. USA, 88, 3782-3786.
44. 1 progression by E2A and Id helix-loop-helix proteins. EMBO J., 13, 4291-4301.
45. 1 phase in rodent fibroblasts. Genes Dev., 7, 1559-1571.
46. Rane, S.G., Dubus, P., Mettus, R.V., Galbreath, E.J., Boden, G., Reddy, E.P. and Barbacid, M. (1999) Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia. Nature Genet., 22, 44-52.
47. Rao, S.S., Chu, C. and Kohtz, D.S. (1994) Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol., 14, 5259-5267.
48. Rudnicki, M.A. and Jaenisch, R. (1995) The MyoD family of transcription factors and skeletal myogenesis. BioEssays, 17, 203-209.
49. -/- myogenic cells derived from adult skeletal muscle. J. Cell Biol., 144, 631-643.
50. -/- muscle cells. Science. 264, 1467-1471.
51. Serrano, M., Hannon, G.J. and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707.
52. 1-phase progression. Genes Dev., 13, 1501-1512.
53. Shirakata, M., Friedman, F.K., Wei, Q. and Paterson, B.M. (1993) Dimerization specificity of myogenic helix-loop-helix DNA-binding factors directed by nonconserved hydrophilic residues. Genes Dev., 7, 2456-2470.
54. Skapek, S.X., Rhee, J., Spicer, D.B. and Lassar, A.B. (1995) Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science, 267, 1022-1024.
55. Skapek, S.X., Rhee, J., Kim, P.S., Novitch, B.G. and Lassar, A.B. (1996) Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol. Cell. Biol., 16, 7043-7053.
56. Sorrentino, V., Pepperkok, R., Davis, R.L., Ansorge, W. and Philipson, L. (1990) Cell proliferation inhibited by MyoD1 independently of myogenic differentiation. Nature, 345, 813-815.
57. Tapscott, S.J., Davis, R.L., Thayer, M.J., Cheng, P.F., Weintraub, H. and Lassar, A.B. (1988) MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science, 242, 405-411.
58. Wang, J., Huang, Q., Tang, W. and Nadal-Ginard, B. (1996) E2F1 inhibition of transcription activation by myogenic basic helix-loop-helix regulators. J. Cell Biochem., 62, 405-410.
59. Weintraub, H. (1993) The MyoD family and myogenesis: redundancy, networks and thresholds. Cell. 75, 1241-1244.
60. Yablonka-Reuveni, Z., Rudnicki, M.A., Rivera, A.J., Primig, M., Anderson, J.E. and Natanson, P. (1999) The transition from proliferation to differentiation is delayed in satellite cells from mice lacking MyoD. Dev. Biol., 210, 440-455.
61. Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev., 11, 973-983.
62. Zhang, H., Hannon, G.J. and Beach, D. (1994) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev., 8, 1750-1758.
63. Zhang, J.-M., Wei, Q., Zhao, X. and Paterson, B.M. (1999) Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. EMBO J., 18, 926-933.
64. KIP2 control muscle differentiation at the myogenin step. Genes Dev., 13, 213-224.